C02KX Antihypertensives for pulmonary arterial hypertension
ATC group of level 4 – chemical subgroup · in plain English: medicines for high blood pressure
This site has the patient leaflet or the SPC of 39 medicines in this group and its subgroups.
- 30 prescription only (POM)
- 6 no longer supplied or not available
Place in the ATC classification
- C Cardiovascular system drugs 1,712 medicines
- C02 Antihypertensives 133 medicines
- C02K Other antihypertensives 39 medicines
-
C02KX Antihypertensives for pulmonary arterial hypertension 39 medicines
- C02KX01 bosentan 13 medicines
- C02KX02 ambrisentan 16 medicines
- C02KX03 sitaxentan 1 medicine
- C02KX04 macitentan 3 medicines
- C02KX05 riociguat 6 medicines
-
C02KX Antihypertensives for pulmonary arterial hypertension 39 medicines
- C02K Other antihypertensives 39 medicines
- C02 Antihypertensives 133 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Ambrisentan 16 medicines
- Bosentan 13 medicines
- Macitentan 3 medicines
- Riociguat 6 medicines
- Sitaxentan sodium 1 medicine
Medicines in the group and its subgroups
Other names of the ATC group
- Czech: C02KX Jiná antihypertenziva
- French: C02KX autres antihypertenseurs
- German: C02KX Antihypertensiva zur Behandlung der pulmonalen arteriellen Hypertonie
- German: C02KX Antihypertensiva zur Behandlung der pulmonalen arteriellen Hypertonie
- Italian: C02KX Antipertensivi per l'ipertensione arteriosa polmonare
- Polish: C02KX Inne leki przeciwnadciśnieniowe
- Turkish: C02KX Pulmoner arteriyel hipertansiyon için antihipertansifler
- Portuguese (Brazil): C02KX Outros anti-hipertensores
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group C02KX
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
